Epstein Secrets

The New York Times (12/7, Graham-Mclay, 18.61M) reports that an official commission in New Zealand has concluded that "there was 'no plausible way" Christchurch mosque attacker Brenton Tarrant's plans "could have been detected by New Zealand's government agencies 'except by chance." Still, the inquiry "faul

whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the EFTA00135860 British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times

quiry-report.html> (12/7, Graham-Mclay, 18.61M) reports that an official commission in New Zealand has concluded that "there was 'no plausible way' Christchurch mosque attacker Brenton Tarrant's plans "could have been detected by New Zealand's government agencies 'except by chance.' Still, the inquiry "fault

l linked to Du, whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times

The New York Times (12/7, Graham-Mclay, 18.61M) reports that an official commission in New Zealand has concluded that "there was `no plausible way' Christchurch mosque attacker Brenton Tarrant's plans "could have been detected by New Zealand's government agencies `except by chance.' Still, the inquiry "faul

linked to Du, whose company "will be the exclusive manufacturer in mainland China for the vaccine made by the British-Swedish pharmaceutical giant AstraZeneca, and the companies could work together on deals for other countries. The Chinese company is also in early trials for its own candidate." The Times